AptarEastman

Aptar vs Eastman

Aptar designs and manufactures dispensing systems, drug delivery devices, and closures that give consumer and pharmaceutical products their functionality, while Eastman Chemical produces specialty mat...

Investment Analysis

Pros

  • Analysts generally have a strong buy consensus on AptarGroup, forecasting significant stock price appreciation of around 25-35% over the next year.
  • AptarGroup operates in diversified end markets including pharmaceutical, beauty, personal care, and food and beverage, reducing sector-specific risk.
  • The company shows solid profitability with a trailing twelve months net income of approximately $391 million and a moderate P/E ratio around 23, reflecting reasonable valuation.

Considerations

  • Despite positive outlooks, recent trading shows some downward price pressure with a short-term decline of over 1%, indicating possible near-term volatility.
  • The company’s beta of 0.57 suggests lower volatility compared to the market but also potentially less upside during bullish market conditions.
  • Exposure to health and consumer products sectors subject AptarGroup to cyclical risks tied to consumer spending and global supply chain disruptions.

Pros

  • Eastman Chemical has a strong global presence in specialty chemicals, providing diversified revenue streams across automotive, building, and consumer markets.
  • Recent investments focus on sustainability and circular economy initiatives, positioning Eastman well amid growing regulatory and environmental demands.
  • The company maintains solid operational cash flow and has shown resilience in managing raw material cost volatility through pricing power and efficiency improvements.

Considerations

  • Eastman’s earnings remain sensitive to cyclical fluctuations in key end markets such as automotive production and construction activity, which could impact revenue stability.
  • The chemical industry faces regulatory risks and increasing raw material costs that may pressure margins despite the company’s cost control efforts.
  • Execution risks exist around Eastman’s strategic transformation and sustainability initiatives, where delays or higher costs could weigh on near-term profitability.

Buy ATR or EMN in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

ATR
ATR$124.44
vs
EMN
EMN$70.39